Skip to content

Zyla Life Sciences

CIK 0001586105

← back to feed
Revenue (TTM)
$71.64M
+4,380.4% YoY Q1 May 2020
Net Income (TTM)
−$46.64M
−143.5% YoY Q1 May 2020
EPS Diluted (TTM)
$0.03
+106.5% YoY Q1 May 2020
Gross Margin
—
Q1 May 2020
Operating Margin
-83.9%
Q1 May 2020
Net Margin
-65.1%
Q1 May 2020
Free Cash Flow (TTM)
−$14.64M
Q1 May 2020
Cash
$14.54M
Q1 May 2020
Total Debt
$103.28M
Q1 May 2020
Shares Outstanding
9.61M sh
Q1 May 2020

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings